Report Thumbnail
Product Code LP0913110485VU1
Published Date 2024/2/6
English116 PagesGlobal

Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Market Growth 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP0913110485VU1◆The Feb 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/2/6
English 116 PagesGlobal

Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Market Growth 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

The medical cerebrospinal fluid (CSF) shunt system is mainly used to treat hydrocephalus and is a commonly used device in neurosurgery.
The global Medical Cerebral Spinal Fluid (CSF) Shunt Systems market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Medical Cerebral Spinal Fluid (CSF) Shunt Systems Industry Forecast” looks at past sales and reviews total world Medical Cerebral Spinal Fluid (CSF) Shunt Systems sales in 2023, providing a comprehensive analysis by region and market sector of projected Medical Cerebral Spinal Fluid (CSF) Shunt Systems sales for 2024 through 2030. With Medical Cerebral Spinal Fluid (CSF) Shunt Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Cerebral Spinal Fluid (CSF) Shunt Systems industry.
This Insight Report provides a comprehensive analysis of the global Medical Cerebral Spinal Fluid (CSF) Shunt Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Cerebral Spinal Fluid (CSF) Shunt Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Cerebral Spinal Fluid (CSF) Shunt Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Cerebral Spinal Fluid (CSF) Shunt Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Cerebral Spinal Fluid (CSF) Shunt Systems.
United States market for Medical Cerebral Spinal Fluid (CSF) Shunt Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Medical Cerebral Spinal Fluid (CSF) Shunt Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Medical Cerebral Spinal Fluid (CSF) Shunt Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Medical Cerebral Spinal Fluid (CSF) Shunt Systems players cover Sophysa, Anuncia Medical, Medtronic, Integra LifeSciences and B Braun, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Cerebral Spinal Fluid (CSF) Shunt Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Fixed
Adjustable
Segmentation by application
Hospital
Surgery Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sophysa
Anuncia Medical
Medtronic
Integra LifeSciences
B Braun
J & J
Spiegelberg
Natus Medical
Dispomedica
Delta Surgical
Argi Group
Moller Medical
G Surgiwear
Wellong Instruments
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Cerebral Spinal Fluid (CSF) Shunt Systems market?
What factors are driving Medical Cerebral Spinal Fluid (CSF) Shunt Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Cerebral Spinal Fluid (CSF) Shunt Systems market opportunities vary by end market size?
How does Medical Cerebral Spinal Fluid (CSF) Shunt Systems break out type, application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Annual Sales 2019-2030
      • 2.1.2 World Current & Future Analysis for Medical Cerebral Spinal Fluid (CSF) Shunt Systems by Geographic Region, 2019, 2023 & 2030
      • 2.1.3 World Current & Future Analysis for Medical Cerebral Spinal Fluid (CSF) Shunt Systems by Country/Region, 2019, 2023 & 2030
    • 2.2 Medical Cerebral Spinal Fluid (CSF) Shunt Systems Segment by Type
      • 2.2.1 Fixed
      • 2.2.2 Adjustable
    • 2.3 Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Type
      • 2.3.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales Market Share by Type (2019-2024)
      • 2.3.2 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Revenue and Market Share by Type (2019-2024)
      • 2.3.3 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sale Price by Type (2019-2024)
    • 2.4 Medical Cerebral Spinal Fluid (CSF) Shunt Systems Segment by Application
      • 2.4.1 Hospital
      • 2.4.2 Surgery Center
      • 2.4.3 Others
    • 2.5 Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Application
      • 2.5.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sale Market Share by Application (2019-2024)
      • 2.5.2 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Revenue and Market Share by Application (2019-2024)
      • 2.5.3 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sale Price by Application (2019-2024)
  • 3 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems by Company

    • 3.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Breakdown Data by Company
      • 3.1.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Annual Sales by Company (2019-2024)
      • 3.1.2 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales Market Share by Company (2019-2024)
    • 3.2 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Annual Revenue by Company (2019-2024)
      • 3.2.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Revenue by Company (2019-2024)
      • 3.2.2 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Revenue Market Share by Company (2019-2024)
    • 3.3 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sale Price by Company
    • 3.4 Key Manufacturers Medical Cerebral Spinal Fluid (CSF) Shunt Systems Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Location Distribution
      • 3.4.2 Players Medical Cerebral Spinal Fluid (CSF) Shunt Systems Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Medical Cerebral Spinal Fluid (CSF) Shunt Systems by Geographic Region

    • 4.1 World Historic Medical Cerebral Spinal Fluid (CSF) Shunt Systems Market Size by Geographic Region (2019-2024)
      • 4.1.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Annual Sales by Geographic Region (2019-2024)
      • 4.1.2 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Annual Revenue by Geographic Region (2019-2024)
    • 4.2 World Historic Medical Cerebral Spinal Fluid (CSF) Shunt Systems Market Size by Country/Region (2019-2024)
      • 4.2.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Annual Sales by Country/Region (2019-2024)
      • 4.2.2 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Annual Revenue by Country/Region (2019-2024)
    • 4.3 Americas Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales Growth
    • 4.4 APAC Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales Growth
    • 4.5 Europe Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales Growth
    • 4.6 Middle East & Africa Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales Growth
  • 5 Americas

    • 5.1 Americas Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Country
      • 5.1.1 Americas Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Country (2019-2024)
      • 5.1.2 Americas Medical Cerebral Spinal Fluid (CSF) Shunt Systems Revenue by Country (2019-2024)
    • 5.2 Americas Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Type
    • 5.3 Americas Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Region
      • 6.1.1 APAC Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Region (2019-2024)
      • 6.1.2 APAC Medical Cerebral Spinal Fluid (CSF) Shunt Systems Revenue by Region (2019-2024)
    • 6.2 APAC Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Type
    • 6.3 APAC Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Medical Cerebral Spinal Fluid (CSF) Shunt Systems by Country
      • 7.1.1 Europe Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Country (2019-2024)
      • 7.1.2 Europe Medical Cerebral Spinal Fluid (CSF) Shunt Systems Revenue by Country (2019-2024)
    • 7.2 Europe Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Type
    • 7.3 Europe Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Medical Cerebral Spinal Fluid (CSF) Shunt Systems by Country
      • 8.1.1 Middle East & Africa Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Country (2019-2024)
      • 8.1.2 Middle East & Africa Medical Cerebral Spinal Fluid (CSF) Shunt Systems Revenue by Country (2019-2024)
    • 8.2 Middle East & Africa Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Type
    • 8.3 Middle East & Africa Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Medical Cerebral Spinal Fluid (CSF) Shunt Systems
    • 10.3 Manufacturing Process Analysis of Medical Cerebral Spinal Fluid (CSF) Shunt Systems
    • 10.4 Industry Chain Structure of Medical Cerebral Spinal Fluid (CSF) Shunt Systems
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Medical Cerebral Spinal Fluid (CSF) Shunt Systems Distributors
    • 11.3 Medical Cerebral Spinal Fluid (CSF) Shunt Systems Customer
  • 12 World Forecast Review for Medical Cerebral Spinal Fluid (CSF) Shunt Systems by Geographic Region

    • 12.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Market Size Forecast by Region
      • 12.1.1 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Forecast by Region (2025-2030)
      • 12.1.2 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Annual Revenue Forecast by Region (2025-2030)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Forecast by Type
    • 12.7 Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Sophysa
      • 13.1.1 Sophysa Company Information
      • 13.1.2 Sophysa Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.1.3 Sophysa Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.1.4 Sophysa Main Business Overview
      • 13.1.5 Sophysa Latest Developments
    • 13.2 Anuncia Medical
      • 13.2.1 Anuncia Medical Company Information
      • 13.2.2 Anuncia Medical Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.2.3 Anuncia Medical Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.2.4 Anuncia Medical Main Business Overview
      • 13.2.5 Anuncia Medical Latest Developments
    • 13.3 Medtronic
      • 13.3.1 Medtronic Company Information
      • 13.3.2 Medtronic Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.3.3 Medtronic Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.3.4 Medtronic Main Business Overview
      • 13.3.5 Medtronic Latest Developments
    • 13.4 Integra LifeSciences
      • 13.4.1 Integra LifeSciences Company Information
      • 13.4.2 Integra LifeSciences Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.4.3 Integra LifeSciences Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.4.4 Integra LifeSciences Main Business Overview
      • 13.4.5 Integra LifeSciences Latest Developments
    • 13.5 B Braun
      • 13.5.1 B Braun Company Information
      • 13.5.2 B Braun Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.5.3 B Braun Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.5.4 B Braun Main Business Overview
      • 13.5.5 B Braun Latest Developments
    • 13.6 J & J
      • 13.6.1 J & J Company Information
      • 13.6.2 J & J Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.6.3 J & J Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.6.4 J & J Main Business Overview
      • 13.6.5 J & J Latest Developments
    • 13.7 Spiegelberg
      • 13.7.1 Spiegelberg Company Information
      • 13.7.2 Spiegelberg Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.7.3 Spiegelberg Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.7.4 Spiegelberg Main Business Overview
      • 13.7.5 Spiegelberg Latest Developments
    • 13.8 Natus Medical
      • 13.8.1 Natus Medical Company Information
      • 13.8.2 Natus Medical Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.8.3 Natus Medical Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.8.4 Natus Medical Main Business Overview
      • 13.8.5 Natus Medical Latest Developments
    • 13.9 Dispomedica
      • 13.9.1 Dispomedica Company Information
      • 13.9.2 Dispomedica Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.9.3 Dispomedica Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.9.4 Dispomedica Main Business Overview
      • 13.9.5 Dispomedica Latest Developments
    • 13.10 Delta Surgical
      • 13.10.1 Delta Surgical Company Information
      • 13.10.2 Delta Surgical Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.10.3 Delta Surgical Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.10.4 Delta Surgical Main Business Overview
      • 13.10.5 Delta Surgical Latest Developments
    • 13.11 Argi Group
      • 13.11.1 Argi Group Company Information
      • 13.11.2 Argi Group Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.11.3 Argi Group Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.11.4 Argi Group Main Business Overview
      • 13.11.5 Argi Group Latest Developments
    • 13.12 Moller Medical
      • 13.12.1 Moller Medical Company Information
      • 13.12.2 Moller Medical Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.12.3 Moller Medical Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.12.4 Moller Medical Main Business Overview
      • 13.12.5 Moller Medical Latest Developments
    • 13.13 G Surgiwear
      • 13.13.1 G Surgiwear Company Information
      • 13.13.2 G Surgiwear Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.13.3 G Surgiwear Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.13.4 G Surgiwear Main Business Overview
      • 13.13.5 G Surgiwear Latest Developments
    • 13.14 Wellong Instruments
      • 13.14.1 Wellong Instruments Company Information
      • 13.14.2 Wellong Instruments Medical Cerebral Spinal Fluid (CSF) Shunt Systems Product Portfolios and Specifications
      • 13.14.3 Wellong Instruments Medical Cerebral Spinal Fluid (CSF) Shunt Systems Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.14.4 Wellong Instruments Main Business Overview
      • 13.14.5 Wellong Instruments Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.